Treatment of degenerative eye disorders

Details Treatment of degenerative eye disorders Treatment of degenerative eye disorders

1995-11-27

1999-04-06

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

519 13, 519 14, 530324, 530326, 530327, 530312, 530301, A61K 3800, C07K 500, C07K 1600, C07K 1700

Patent

active

058918477

ABSTRACT:
Retinal dystrophies are treated by melanotropin peptides or analogs.

REFERENCES:
patent: 4868154 (1989-09-01), Gilbard et al.
T. Hanaoka, "Effect of Melanophore Hormone on Regeneration of Visual Purple in Solution", Nature, vol. 172, 1953, p. 866.
O.G. Stroeva, et al., "A Hormone-Sensitive Stage in Development of the Retinal Pigment Epithelium in the Hunter Rats with Inherited Retinal Distrophy", Ontogenez, vol. 19, No. 1, 1988, pp. 30-36.

Affiliated with

Also associated with

Rating

Treatment of degenerative eye disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of degenerative eye disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of degenerative eye disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1371407